anmelden
Analysen von Richard Vosser
| 03.01.17 | Roche overweight | JP Morgan Chase & Co. | |
| 03.01.17 | Bayer overweight | JP Morgan Chase & Co. | |
| 13.12.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 06.12.16 | Roche overweight | JP Morgan Chase & Co. | |
| 29.11.16 | Roche overweight | JP Morgan Chase & Co. | |
| 18.11.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 26.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 10.10.16 | Novartis overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 10.10.16 | Roche overweight | JP Morgan Chase & Co. | |
| 07.10.16 | Roche overweight | JP Morgan Chase & Co. | |
| 29.09.16 | Roche overweight | JP Morgan Chase & Co. | |
| 13.09.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 02.09.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.08.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.08.16 | Roche overweight | JP Morgan Chase & Co. | |
| 03.08.16 | Roche overweight | JP Morgan Chase & Co. | |
| 22.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 21.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 18.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.07.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.07.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 11.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 01.07.16 | Roche overweight | JP Morgan Chase & Co. | |
| 15.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 13.06.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.06.16 | Roche overweight | JP Morgan Chase & Co. | |
| 31.05.16 | Roche overweight | JP Morgan Chase & Co. | |
| 26.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 19.05.16 | Roche overweight | JP Morgan Chase & Co. | |
| 03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 20.04.16 | Roche overweight | JP Morgan Chase & Co. | |
| 20.04.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 12.04.16 | Roche overweight | JP Morgan Chase & Co. | |
| 01.04.16 | Roche overweight | JP Morgan Chase & Co. | |
| 29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.03.16 | Roche overweight | JP Morgan Chase & Co. | |
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.02.16 | Novartis kaufen | JP Morgan Chase & Co. | |
| 04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
